ATE375393T1 - Verfahren zur herstellung eines peptids mittels eines hilfspeptids - Google Patents

Verfahren zur herstellung eines peptids mittels eines hilfspeptids

Info

Publication number
ATE375393T1
ATE375393T1 AT99901926T AT99901926T ATE375393T1 AT E375393 T1 ATE375393 T1 AT E375393T1 AT 99901926 T AT99901926 T AT 99901926T AT 99901926 T AT99901926 T AT 99901926T AT E375393 T1 ATE375393 T1 AT E375393T1
Authority
AT
Austria
Prior art keywords
peptide
target
protein
producing
solubility
Prior art date
Application number
AT99901926T
Other languages
English (en)
Inventor
Kazuhiro Ohsuye
Masayuki Yabuta
Yuji Suzuki
Original Assignee
Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asubio Pharma Co Ltd filed Critical Asubio Pharma Co Ltd
Application granted granted Critical
Publication of ATE375393T1 publication Critical patent/ATE375393T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99901926T 1998-01-30 1999-01-29 Verfahren zur herstellung eines peptids mittels eines hilfspeptids ATE375393T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3227298 1998-01-30

Publications (1)

Publication Number Publication Date
ATE375393T1 true ATE375393T1 (de) 2007-10-15

Family

ID=12354362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99901926T ATE375393T1 (de) 1998-01-30 1999-01-29 Verfahren zur herstellung eines peptids mittels eines hilfspeptids

Country Status (12)

Country Link
EP (1) EP0978565B1 (de)
JP (1) JP4331270B2 (de)
KR (1) KR100627590B1 (de)
CN (1) CN1198937C (de)
AT (1) ATE375393T1 (de)
AU (1) AU765206B2 (de)
CA (1) CA2284847A1 (de)
DE (1) DE69937272T2 (de)
DK (1) DK0978565T3 (de)
IL (1) IL132030A (de)
NZ (1) NZ338004A (de)
WO (1) WO1999038984A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052193A1 (fr) 1999-03-04 2000-09-08 Suntory Limited Procede de controle de clivage par la protease de l'ompt
WO2001027310A1 (fr) * 1999-10-15 2001-04-19 Shionogi & Co., Ltd. Procede de production d'un precurseur d'adrenomeduline
KR100407792B1 (ko) * 2000-08-02 2003-12-01 한국생명공학연구원 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ATE469915T1 (de) 2001-07-27 2010-06-15 Novartis Vaccines & Diagnostic Antikörper gegen das meningokokken adhäsin app
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
US8129504B2 (en) 2001-08-30 2012-03-06 Biorexis Technology, Inc. Oral delivery of modified transferrin fusion proteins
CN100491395C (zh) 2002-04-11 2009-05-27 阿斯比奥制药株式会社 修饰肽的制造方法
CA2485701A1 (en) * 2002-05-24 2003-12-04 Fred W. Wagner Method for enzymatic production of glp-1 (7-36) amide peptides
CA2485695A1 (en) 2002-05-24 2003-12-04 Fred W. Wagner Method for universal enzymatic production of bioactive peptides
AU2003243316A1 (en) 2002-05-24 2003-12-12 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
JPWO2004037859A1 (ja) * 2002-10-11 2006-02-23 株式会社三和化学研究所 Glp−1誘導体及びその経粘膜吸収型製剤
HUE031886T2 (en) 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
EP1626981A4 (de) * 2003-03-04 2006-11-22 Biorexis Pharmaceutical Corp Dipeptidylpeptidase-geschützte proteine
HRP20120315T1 (hr) 2003-11-21 2012-05-31 Nps Pharmaceuticals Proizvodnja peptida 2 nalik glukagonu i analoga
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
DK2038423T3 (da) 2006-06-21 2013-04-02 Biocon Ltd Fremgangsmåde til fremstilling af biologisk aktive polypeptider med insulinotropisk aktivitet
CN101511868B (zh) 2006-07-24 2013-03-06 比奥雷克西斯制药公司 毒蜥外泌肽融合蛋白
CA2663047A1 (en) * 2006-09-06 2008-03-13 Phase Bioscience, Inc. Therapeutic elastin-like polypeptide (elp) fusion proteins
CN102131516B (zh) 2008-06-27 2016-03-16 杜克大学 包含弹性蛋白样肽的治疗剂
CN104936610A (zh) * 2012-11-13 2015-09-23 益普生制药股份有限公司 Glp-1类似物的纯化方法
CN104592381A (zh) * 2013-10-31 2015-05-06 江苏万邦生化医药股份有限公司 一种利拉鲁肽中间体多肽的制备方法
RU2544959C1 (ru) * 2014-04-04 2015-03-20 Александр Владимирович Бубнов Способ получения пептидов
CN107532190B (zh) 2014-12-01 2021-07-09 菲尼克斯公司 用于肽生产的融合伴侣
CN105669856A (zh) * 2016-02-13 2016-06-15 王大勇 一种基因重组长效人促肾上腺皮质激素及其制备方法
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
CN111378027B (zh) * 2018-12-29 2022-04-15 万新医药科技(苏州)有限公司 一种索玛鲁肽前体的制备方法
JP7761567B2 (ja) 2020-02-18 2025-10-28 ノヴォ ノルディスク アー/エス 医薬製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3531947B2 (ja) * 1991-08-19 2004-05-31 第一サントリーファーマ株式会社 ペプチドの製造方法
JP3995279B2 (ja) * 1994-09-07 2007-10-24 アスビオファーマ株式会社 蛋白の製造方法
CA2198966C (en) * 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme

Also Published As

Publication number Publication date
WO1999038984A1 (fr) 1999-08-05
CA2284847A1 (en) 1999-08-05
AU2185799A (en) 1999-08-16
EP0978565A1 (de) 2000-02-09
DK0978565T3 (da) 2008-02-04
IL132030A0 (en) 2001-03-19
KR20010005859A (ko) 2001-01-15
CN1255945A (zh) 2000-06-07
DE69937272D1 (de) 2007-11-22
IL132030A (en) 2009-06-15
NZ338004A (en) 2001-08-31
KR100627590B1 (ko) 2006-09-25
EP0978565B1 (de) 2007-10-10
JP4331270B2 (ja) 2009-09-16
DE69937272T2 (de) 2008-07-10
EP0978565A4 (de) 2003-05-02
CN1198937C (zh) 2005-04-27
AU765206B2 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
ATE375393T1 (de) Verfahren zur herstellung eines peptids mittels eines hilfspeptids
ATE353911T1 (de) Verfahren zur rekombinanten herstellung von antifusogenikpeptide
ATE372383T1 (de) Verfahren zur herstellung von l-aminosäuren
DE60030988D1 (de) Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH
EP1350842A3 (de) Rekombinante terminale Deoxynukleotidyltransferase mit verbesserter Funktionalität
PT670896E (pt) Clonagem e expressao de alfa-galactosidase biologicamente activa
DE60011974D1 (de) Verfahren zur Herstellung von L-Aminosäuren mittels Fermentation eines Escherichia Stammes, transformiert mit einem Pyruvat-carboxylase Gen aus Bacillus subtilis
EA200100387A1 (ru) Роль секретазы в болезни альцгеймера
EA200600408A1 (ru) Получение l-аскорбиновой кислоты в результате микробиологического процесса
ATE406447T1 (de) Neue carbonylreduktase, diese codierendes gen und verfahren zur produktion optisch-aktiver alkohole damit
ATE273269T1 (de) Verfahren zur abtrennung von einer basischen aminosäure aus fermentationsbrühen
ATE461997T1 (de) Neuartige glukose-6-phosphat dehydrogenase
TR200000086T2 (tr) Heparin üretimi için işlem.
ATE386134T1 (de) Verfahren zur herstellung von glutathion
ATE488597T1 (de) Verfahren zur herstellung optisch aktiver aminosäuren unter verwendung eines ganzzellenkatalysators
DE50102109D1 (de) Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
ATE439430T1 (de) Mutanten für die herstellung von d-aminosäuren
ATE319850T1 (de) Verfahren zur herstellung von aminosäuren
ATE399152T1 (de) Verfahren zur herstellung von optisch aktiven azetidin-2-carbonsäuren
DE69730444D1 (de) Verfahren zur herstellung optisch aktiven n-benzyl-3-pyrrolidinols
EP1273665A4 (de) Verfahren zur herstellung von optisch aktiven beta-amino alkoholen
ATE291094T1 (de) Verfahren zur herstellung von nukleosidderivaten
ATE202146T1 (de) Verbesserte enzymatische kupplungsreaktion von n- geschützte l-asparaginsäure und phenylalaninmethylester
DE69520844D1 (de) Verfahren zur Verhinderung der Zersetzung des Proteins C
RU2001117632A (ru) Способ получения l-аминокислот с использованием бактерий, принадлежащих к роду escherichia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0978565

Country of ref document: EP